UBS O'Connor’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-65,866
Closed -$1.41M 378
2025
Q2
$1.41M Sell
65,866
-8,996
-12% -$194K 0.04% 181
2025
Q1
$1.84M Buy
74,862
+9,570
+15% +$236K 0.04% 133
2024
Q4
$1.51M Buy
65,292
+13,270
+26% +$332K 0.04% 187
2024
Q3
$1.41M Buy
52,022
+3,925
+8% +$119K 0.03% 234
2024
Q2
$1.38M Sell
48,097
-16,717
-26% -$512K 0.04% 251
2024
Q1
$1.89M Buy
64,814
+24,500
+61% +$685K 0.05% 182
2023
Q4
$1.31M Sell
40,314
-15,905
-28% -$461K 0.04% 237
2023
Q3
$1.8M Buy
56,219
+11,000
+24% +$424K 0.03% 259
2023
Q2
$1.98M Sell
45,219
-4,427
-9% -$204K 0.04% 294
2023
Q1
$2.2M Buy
+49,646
New +$2.19M 0.05% 301
2022
Q4
Sell
-36,448
Closed -$1.68M 171
2022
Q3
$1.68M Sell
36,448
-8,500
-19% -$417K 0.02% 669
2022
Q2
$1.94M Buy
+44,948
New +$2.06M 0.02% 663

Other funds holding KIDS

UBS O'Connor's KIDS Position: Q3 2025 in Review

UBS O'Connor sold out of OrthoPediatrics (KIDS) in Q3 2025, closing a stake of 65,866 shares — an estimated $1.41M sold.

UBS O'Connor first reported a position in KIDS in Q2 2022 and held it in 12 quarters. The position peaked at $2.2M in Q1 2023. 111 funds tracked by Wall St. Rank hold KIDS as of Q3 2025.

  • UBS O'Connor reported no remaining OrthoPediatrics position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 65,866 OrthoPediatrics shares in Q3 2025, an estimated $1.41M.
  • UBS O'Connor first reported a position in OrthoPediatrics in Q2 2022 and held it in 12 quarters.
  • UBS O'Connor's OrthoPediatrics position peaked at $2.2M in Q1 2023.
  • 111 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.